{"protocolSection":{"identificationModule":{"nctId":"NCT03971526","orgStudyIdInfo":{"id":"29426989"},"organization":{"fullName":"Fondation Ophtalmologique Adolphe de Rothschild","class":"NETWORK"},"briefTitle":"Magnetic Resonance Post-contrast Vascular Hyperintensities at 3 T: a Sensitive Sign of Vascular Occlusion in Acute Ischaemic Stroke","officialTitle":"Magnetic Resonance Post-contrast Vascular Hyperintensities at 3 T: a New Highly Sensitive Sign of Vascular Occlusion in Acute Ischaemic Stroke"},"statusModule":{"statusVerifiedDate":"2019-05","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2014-09-01","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2016-09-01","type":"ACTUAL"},"completionDateStruct":{"date":"2016-09-01","type":"ACTUAL"},"studyFirstSubmitDate":"2019-05-26","studyFirstSubmitQcDate":"2019-05-31","studyFirstPostDateStruct":{"date":"2019-06-03","type":"ACTUAL"},"lastUpdateSubmitDate":"2019-05-31","lastUpdatePostDateStruct":{"date":"2019-06-03","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Fondation Ophtalmologique Adolphe de Rothschild","class":"NETWORK"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Magnetic resonance imaging (MRI) is the diagnostic cornerstone for precisely identifying acute ischaemic strokes and locating vascular occlusions.\n\nIt was observed that a post-contrast three-dimensional turbo-spin-echo T1weighted sequence showed striking post-contrast vascular hyperintensities (PCVH) in ischaemic territories. The aim is to evaluate the prevalence and the meaning of this finding.\n\nThis study included 130 consecutive patients admitted for acute ischaemic stroke with a 3-T MRI performed in the first 12 h of symptom onset from September 2014 through September 2016. Two neuroradiologists blinded to clinical data analysed the first MRI assessments."},"conditionsModule":{"conditions":["Acute Ischaemic Stroke"],"keywords":["Cerebrovascular disorders","Magnetic resonance imaging","Neuroimaging","Prognosis","Stroke"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"OTHER","timePerspective":"RETROSPECTIVE"},"enrollmentInfo":{"count":130,"type":"ACTUAL"}},"armsInterventionsModule":{"interventions":[{"type":"OTHER","name":"MRI images review","description":"MR images were reviewed by one junior radiologist and one senior neuroradiologist, both blinded to clinical, therapeutic and follow-up data."}]},"outcomesModule":{"primaryOutcomes":[{"measure":"overal survival","description":"from the AR-PML diagnosis date to that of death or censored on 31 December 2015","timeFrame":"7 years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion criteria:\n\n* Patients aged 18 and older at onset of an acute ischaemic stroke\n* Availability of at least one pre-therapeutic MRI performed in our centre within 12 h of stroke onset, including a post-contrast 3D TSE T1-weighted sequence.\n\nExclusion criteria:\n\n* Patients with posterior fossa strokes\n* Patients with known intracranial vasculitis or MoyaMoya disease\n* Presence of severe MR imaging artefacts preventing correct interpretation","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"130 consecutive patients admitted for acute ischaemic stroke with a 3-T MRI performed in the first 12 h of symptom onset.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9708","name":"Hypersensitivity","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC20","name":"Immune System Diseases"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}